Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Isomorphic Labs secured £1.6 billion in a Series B funding round, marking a significant milestone in European biotech history.

PRIVATEAug 07, 2026•2 days ago

Amount Raised

£1.6 Billion

Round Type

Series B

LondonBiotechnologyArtificial Intelligence

Description

Isomorphic Labs raised £1.6 billion in a Series B funding round, making it one of the largest private financings in European biotech history. This significant capital injection highlights a robust interest in the UK biotech sector amid global instability. The funding denotes a positive shift as the sector recovers from a prolonged downturn. Overall, UK biotech companies raised £2.05 billion in venture capital in Q2 2026.

Company Information

Company

Isomorphic Labs

Location

London, England, United Kingdom

About

Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.

Related People

Suggested for you
2 contacts
Verified contactsJennifer E., Senior Talent Partner hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Isomorphic Labs's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.